Category Archives: Stem Cell Research

Every week there are numerous scientific studies published. Heres a look at some of the more interesting ones. Continue reading →

Myeloablative conditioning with busulfan and fludarabine (bu/flu) may produce similar clinical outcomes and quality of life (QOL) compared with conditioning with busulfan and cyclophosphamide (bu/cy) for allogeneic hematopoietic cell transplantation (alloHCT) in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), according to research published in Hematology/Oncology and Stem Cell Therapy. Although bu/cy and bu/flu are both standard myeloablative conditioning regimens for alloHCT, they have not yet been studied with a focus on quality of life. Researchers conducted a single center, retrospective analysis of adult patients who received a first T-cell-replete human leukocyte antigen-8/8 matched related or unrelated donor alloHCT Continue reading →

Senior pupils from Balwearie High are hoping to save lives after taking part in an Anthony Nolan Trust stem cell recruitment drive recently. The event was held at the school last Friday and saw 125 potential donors sign up by giving cheek swabs. S6 pupil Emily Greig explained how the recruitment drive came about: The school was approached by the Scottish Fire and Rescue Service to hold the event and we immediately thought it was a brilliant way to help people, she said Continue reading →

The International Society for Stem Cell Application (ISSCA), in collaboration with SISDET, held a highly successful three-day medical conference on the University of Miami campus on October 24-26. The conference featured a host of international experts in regenerative medicine and introduced new standards in regenerative medicine protocols to those in attendance Continue reading →

Since 2006, when Shinya Yamanaka, now the director of the Center for iPS Cell Research and Application at Kyoto University, discovered a method that could guide fully differentiated cells back to their pluripotent state, scientists have been using his recipe to produce induced pluripotent stem cells. Continue reading →

NEW YORK, Nov. 12, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced that the Companys Chief Operating and Chief Medical Officer Ralph Kern MD MHSc will present at the 7th International Stem Cell Meeting, which is hosted by the Israel Stem Cell Society. Continue reading →

CAMBRIDGE, Mass. & MENLO PARK, Calif.--(BUSINESS WIRE)-- bluebird bio, Inc. Continue reading →

Laura Beil was skeptical when Wondery called her two years ago. The sensationalistic podcast hitmaker behind Dirty John needed a host for its new series about Christopher Duntsch, the infamous Dallas neurosurgeon accused of maiming his patients. Beil, a veteran Dallas Morning News medical reporter, hadn't listened to a true crime podcast in full, let alone reported one. Continue reading →

Introduction Regulation, by necessity, introduces rigidity to otherwise flexible processes. Done proportionately, this can be an efficient societal device for preventing harm Continue reading →

Thursday, 14 November 2019, 11:49 amPress Release: University of Canterbury Two UC researchers awarded Rutherford FoundationPostdoctoral Fellowships Two outstandingUniversity of Canterbury researchers are among the tennationwide who have been awarded 2019 Rutherford FoundationPostdoctoral Fellowships The two-year RutherfordFoundation Fellowships seek to build human capability inresearch, science and technology by supporting early careerresearchers. Continue reading →